G01N 2800/226
Thrombotic disorders, i.e. thrombo-embolism irrespective of location/organ involved
Official title: Thrombotic disorders, i.e. thrombo-embolism irrespective of location/organ involved, e.g. renal vein thrombosis, venous thrombosis
G01N2800/226 (Thrombotic disorders, i.e. thrombo-embolism irrespective of location/organ involved) appears on 93 US grants and 154 published applications in this corpus.
Search patents in G01N- Granted patents
- 93
- Published applications
- 154
- Assignees
- 119
- Inventors
- 339
- Latest grant
- 16 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1998 | 2 | 0 |
| 1999 | 0 | 0 |
| 2000 | 3 | 0 |
| 2001 | 2 | 1 |
| 2002 | 1 | 3 |
| 2003 | 2 | 2 |
| 2004 | 0 | 2 |
| 2005 | 0 | 0 |
| 2006 | 1 | 3 |
| 2007 | 3 | 5 |
| 2008 | 1 | 2 |
| 2009 | 0 | 4 |
| 2010 | 0 | 8 |
| 2011 | 5 | 5 |
| 2012 | 1 | 7 |
| 2013 | 6 | 6 |
| 2014 | 6 | 6 |
| 2015 | 6 | 8 |
| 2016 | 5 | 15 |
| 2017 | 5 | 9 |
| 2018 | 7 | 12 |
| 2019 | 5 | 8 |
| 2020 | 8 | 6 |
| 2021 | 5 | 9 |
| 2022 | 5 | 7 |
| 2023 | 2 | 5 |
| 2024 | 4 | 12 |
| 2025 | 6 | 5 |
| 2026 | 2 | 4 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Clinical decision support system16 Jun 2026US 12,656,333 B2Instrumentation Laboratory Company
- Methods and kits for identifying thrombus origin and optimizing post-ischemic event treatment13 Jan 2026US 12,522,855 B2Tel HaShomer Medical Research Infrastructure and Services Ltd.
- Methods and systems for determining ADAMTS13 enzyme activity14 Oct 2025US 12,442,030 B2Laboratory Corporation of America Holdings
- Monoclonal antibody against D-dimer and diagnosis agent for detecting D-dimer, crosslinked fibrin and its derivatives containing D-dimer by using the antibody30 Sep 2025US 12,429,488 B2Princeton Biomeditech Corporation
- Fusion protein and high-density lipoprotein measurement kit using same12 Aug 2025US 12,384,831 B2
- Clinical decision support system8 Oct 2026US 2026/0309696 A1Instrumentation Laboratory Company
- Diagnosis method using cell free nucleosome levels24 Sep 2026US 2026/0287594 A1Belgian Volition SRL
- Anti carcinoembryonic antigen-related cell adhesion molecule 1 (ceacam1) antibodies for inhibition of neutrophil extracellular traps (net)-mediated activities18 Jun 2026US 2026/0167717 A1Famewave Ltd.
- Reagent and method for diagnosing thrombotic events22 Jan 2026US 2026/0023088 A1Biokit Research & Development S.L.U.
- Compositions and methods for assaying platelet reactivity and treatment selection30 Oct 2025US 2025/0334575 A1University of Vermont and State Agricultural College
Most cited
By later US patents
- Method of using platelet contractile force and whole blood clot elastic modulus as clinical markers54US 7,192,726 B1Hemodyne, Inc. · 2007
- Onset of force development as a marker of thrombin generation43US 7,202,048 B2Hemodyne, Inc. · 2007
- Method and apparatus for predicting the presence of an abnormal level of one or more proteins in the clotting cascade19US 6,321,164 B1Akzo Nobel N. V. · 2001
- Method for predicting the presence of congenital and therapeutic conditions from coagulation screening assays16US 6,101,449 AAkzo Nobel N. V. · 2000
- Method and apparatus for predicting the presence of congenital and acquired imbalances and therapeutic conditions15US 5,708,591 AAkzo Nobel N. V. · 1998